[go: up one dir, main page]

NO20081488L - Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt - Google Patents

Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt

Info

Publication number
NO20081488L
NO20081488L NO20081488A NO20081488A NO20081488L NO 20081488 L NO20081488 L NO 20081488L NO 20081488 A NO20081488 A NO 20081488A NO 20081488 A NO20081488 A NO 20081488A NO 20081488 L NO20081488 L NO 20081488L
Authority
NO
Norway
Prior art keywords
composition containing
photo
treatment
pharmaceutical composition
stable pharmaceutical
Prior art date
Application number
NO20081488A
Other languages
English (en)
Norwegian (no)
Inventor
Marc Wihsmann
Reinhard Schmitz
Original Assignee
Berlin Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag filed Critical Berlin Chemie Ag
Publication of NO20081488L publication Critical patent/NO20081488L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20081488A 2005-09-29 2008-03-26 Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt NO20081488L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005046769A DE102005046769A1 (de) 2005-09-29 2005-09-29 Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
PCT/EP2006/009383 WO2007039201A2 (en) 2005-09-29 2006-09-27 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis

Publications (1)

Publication Number Publication Date
NO20081488L true NO20081488L (no) 2008-03-26

Family

ID=37561306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081488A NO20081488L (no) 2005-09-29 2008-03-26 Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt

Country Status (33)

Country Link
US (1) US20080249061A1 (es)
EP (1) EP1940353B1 (es)
JP (1) JP2009509993A (es)
KR (1) KR20080053319A (es)
CN (1) CN101272765A (es)
AP (1) AP2008004394A0 (es)
AR (1) AR056551A1 (es)
AT (1) ATE489076T1 (es)
AU (1) AU2006299115A1 (es)
BR (1) BRPI0616449A2 (es)
CA (1) CA2624111A1 (es)
CR (1) CR9839A (es)
CY (1) CY1111059T1 (es)
DE (2) DE102005046769A1 (es)
DK (1) DK1940353T3 (es)
EA (1) EA012975B1 (es)
EC (1) ECSP088310A (es)
ES (1) ES2356774T3 (es)
HN (1) HN2008000497A (es)
HR (1) HRP20110085T1 (es)
IL (1) IL190466A0 (es)
MA (1) MA29887B1 (es)
NO (1) NO20081488L (es)
PE (1) PE20070767A1 (es)
PL (1) PL1940353T3 (es)
PT (1) PT1940353E (es)
RS (1) RS51615B (es)
SI (1) SI1940353T1 (es)
TN (1) TNSN08094A1 (es)
TW (1) TW200744664A (es)
UA (1) UA90911C2 (es)
WO (1) WO2007039201A2 (es)
ZA (1) ZA200802729B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009006130A2 (en) * 2007-06-28 2009-01-08 Bausch & Lomb Incorporated Salt free hyaluronate ophthalmic solution
US20090196833A1 (en) * 2008-02-06 2009-08-06 Adherex Technologies Inc. Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndrome
DE102009003942A1 (de) * 2009-01-07 2010-07-08 D2O Biosience Group Ltd., Hamilton Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges
HUE044329T2 (hu) 2014-01-22 2019-10-28 Visufarma B V Iota-karragént tartalmazó készítmény vírusos kötõhártya-gyulladás ellen
CA3022983C (en) * 2016-05-06 2024-05-07 SaCSh Corp. Ophthalmic compositions comprising chlorhexidine and an anti-inflammatory agent
CN113712928A (zh) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 经口腔粘膜吸收的溴夫定药物
EP4623919A1 (en) 2024-03-28 2025-10-01 Marinomed Biotech AG Composition comprising iota-carrageenan for the treatment of dry eyes, non-viral conjunctivitis and allergic ocular conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations
DE10162593A1 (de) * 2001-12-19 2003-07-03 Menarini Ricerche Spa Stabilisierte topische Brivudin-Formulierungen

Also Published As

Publication number Publication date
AU2006299115A1 (en) 2007-04-12
WO2007039201A3 (en) 2007-10-04
SI1940353T1 (sl) 2011-03-31
JP2009509993A (ja) 2009-03-12
IL190466A0 (en) 2008-11-03
AU2006299115A2 (en) 2008-05-29
CA2624111A1 (en) 2007-04-12
PE20070767A1 (es) 2007-08-13
RS51615B (sr) 2011-08-31
KR20080053319A (ko) 2008-06-12
ES2356774T3 (es) 2011-04-13
MA29887B1 (fr) 2008-10-03
DE102005046769A1 (de) 2007-04-05
ECSP088310A (es) 2008-05-30
EP1940353B1 (en) 2010-11-24
AR056551A1 (es) 2007-10-10
DE602006018505D1 (de) 2011-01-05
ATE489076T1 (de) 2010-12-15
UA90911C2 (ru) 2010-06-10
EA012975B1 (ru) 2010-02-26
US20080249061A1 (en) 2008-10-09
DK1940353T3 (da) 2011-01-24
HN2008000497A (es) 2010-09-10
PL1940353T3 (pl) 2011-05-31
WO2007039201A2 (en) 2007-04-12
TNSN08094A1 (en) 2009-07-14
CN101272765A (zh) 2008-09-24
BRPI0616449A2 (pt) 2011-06-21
AP2008004394A0 (en) 2008-04-30
TW200744664A (en) 2007-12-16
EA200800646A1 (ru) 2008-10-30
CY1111059T1 (el) 2015-06-11
EP1940353A2 (en) 2008-07-09
HRP20110085T1 (hr) 2011-03-31
PT1940353E (pt) 2011-02-25
ZA200802729B (en) 2009-09-30
CR9839A (es) 2008-10-31

Similar Documents

Publication Publication Date Title
NO20081488L (no) Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt
NO20075297L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
NO20074703L (no) Antibakterielle piperidinderivater
WO2006015943A3 (en) Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
WO2007087548A3 (en) Chemical compounds
EP2308867A3 (en) 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
AR054114A1 (es) Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion
NO20090346L (no) Pyrazolderivater som inhibitorer av cytokrom P450
NO20073572L (no) Nye forbindelser
NO20083246L (no) Nye benzimidazolderivater som vanilloid-reseptor 1 (VRL) inhibitorer
NO20091999L (no) MAPK/ERK kinase inhibitorer
NO20060631L (no) Fast dispersjon av takrolimus
DK1838665T3 (da) Mutilinderivater og deres anvendelse som lægemidler
DK1864666T3 (da) Beskyttelsesmiddel til en retinal neuronal celle indeholdende prostaglandin-F2-alfa-derivat som aktiv ingrediens
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
WO2006002077A3 (en) Stable pharmaceutical formulations of benzimidazole compounds
WO2006120563A3 (en) Antibacterial agents
WO2007143456A3 (en) Benzimidazol substituted thiophene derivatives with activity on plk
WO2004078115A3 (en) Benzothiazole compounds, compositions and methods for treatment and prophylaxis of rotavirus infections and associated diseases
NO20082129L (no) Middel til nedbrytning av nukleinsyrer samt fremgangsmate for nedbrytning av nukleinsyrer
WO2009109990A3 (en) Pramipexole composition comprising sugar alcohol(s)
DK2089030T3 (da) Middel til profylakse eller behandling af alkoholafhængighed eller lægemiddelafhængighed
WO2006091847A3 (en) Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
ATE449102T1 (de) Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application